Gene Symbol | Gene ID | Gene Info |
---|---|---|
Gsx1
|
ENSMUSG00000053129.5 | GS homeobox 1 |
Alx1
|
ENSMUSG00000036602.7 | ALX homeobox 1 |
Mixl1
|
ENSMUSG00000026497.7 | Mix1 homeobox-like 1 (Xenopus laevis) |
Lbx2
|
ENSMUSG00000034968.2 | ladybird homeobox 2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr10_103029624_103030791 | Alx1 | 8 | 0.639049 | 0.51 | 3.4e-05 | Click! |
chr10_103026340_103027824 | Alx1 | 1545 | 0.387421 | 0.45 | 3.4e-04 | Click! |
chr10_103027884_103029519 | Alx1 | 74 | 0.965406 | 0.40 | 1.7e-03 | Click! |
chr10_103025069_103025608 | Alx1 | 1123 | 0.513894 | 0.37 | 3.8e-03 | Click! |
chr10_103025819_103025990 | Alx1 | 1689 | 0.372622 | 0.32 | 1.3e-02 | Click! |
chr5_147155422_147156154 | Gsx1 | 32908 | 0.115401 | 0.66 | 8.3e-09 | Click! |
chr5_147187904_147189474 | Gsx1 | 7 | 0.971742 | 0.56 | 3.0e-06 | Click! |
chr5_147154764_147155218 | Gsx1 | 33705 | 0.113860 | 0.53 | 1.1e-05 | Click! |
chr5_147189740_147190929 | Gsx1 | 1638 | 0.312047 | 0.42 | 7.8e-04 | Click! |
chr5_147189490_147189641 | Gsx1 | 869 | 0.536929 | 0.39 | 1.9e-03 | Click! |
chr6_83083574_83084632 | Lbx2 | 2264 | 0.084284 | 0.33 | 1.0e-02 | Click! |
chr6_83088724_83088875 | Lbx2 | 1461 | 0.123667 | 0.20 | 1.3e-01 | Click! |
chr6_83086716_83087078 | Lbx2 | 441 | 0.514681 | -0.18 | 1.7e-01 | Click! |
chr6_83085725_83085876 | Lbx2 | 567 | 0.408787 | 0.18 | 1.8e-01 | Click! |
chr6_83088261_83088418 | Lbx2 | 1001 | 0.202950 | 0.15 | 2.7e-01 | Click! |
chr1_180703341_180703767 | Mixl1 | 6520 | 0.127971 | -0.25 | 5.8e-02 | Click! |
chr1_180698055_180698206 | Mixl1 | 1096 | 0.391856 | 0.24 | 6.1e-02 | Click! |
chr1_180703784_180703937 | Mixl1 | 6826 | 0.126697 | -0.20 | 1.3e-01 | Click! |
chr1_180696356_180697500 | Mixl1 | 106 | 0.948973 | 0.15 | 2.4e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chrX_153501207_153502250 | 15.98 |
Ubqln2 |
ubiquilin 2 |
3501 |
0.22 |
chr2_140668225_140669392 | 14.44 |
Flrt3 |
fibronectin leucine rich transmembrane protein 3 |
2592 |
0.43 |
chr13_15466077_15468087 | 14.19 |
Gli3 |
GLI-Kruppel family member GLI3 |
3102 |
0.22 |
chr18_43686487_43688415 | 13.80 |
Jakmip2 |
janus kinase and microtubule interacting protein 2 |
174 |
0.96 |
chr12_52700044_52701597 | 13.64 |
Akap6 |
A kinase (PRKA) anchor protein 6 |
1437 |
0.46 |
chr9_41585694_41587243 | 13.53 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
1301 |
0.29 |
chr12_49387532_49388566 | 13.50 |
3110039M20Rik |
RIKEN cDNA 3110039M20 gene |
1603 |
0.26 |
chr2_18042311_18043883 | 13.40 |
Skida1 |
SKI/DACH domain containing 1 |
1475 |
0.25 |
chr5_116312100_116312726 | 12.04 |
B230112J18Rik |
RIKEN cDNA B230112J18 gene |
53 |
0.96 |
chr1_19215607_19218714 | 10.96 |
Tfap2b |
transcription factor AP-2 beta |
3281 |
0.25 |
chr7_29071185_29072068 | 10.43 |
Gm26604 |
predicted gene, 26604 |
11 |
0.87 |
chr8_54954519_54955779 | 10.22 |
Gpm6a |
glycoprotein m6a |
306 |
0.88 |
chr1_138346039_138346510 | 10.22 |
Gm28500 |
predicted gene 28500 |
30990 |
0.17 |
chr2_57613916_57615034 | 10.21 |
Gm13532 |
predicted gene 13532 |
14753 |
0.2 |
chr3_134236641_134237783 | 10.17 |
Cxxc4 |
CXXC finger 4 |
392 |
0.78 |
chr10_125967796_125968797 | 10.10 |
Lrig3 |
leucine-rich repeats and immunoglobulin-like domains 3 |
2043 |
0.45 |
chr6_143259703_143261097 | 9.91 |
D6Ertd474e |
DNA segment, Chr 6, ERATO Doi 474, expressed |
14507 |
0.2 |
chr18_37217058_37218378 | 9.77 |
Gm10544 |
predicted gene 10544 |
39196 |
0.08 |
chr3_5224377_5225076 | 9.53 |
Zfhx4 |
zinc finger homeodomain 4 |
3221 |
0.24 |
chr9_35424475_35426234 | 9.51 |
Cdon |
cell adhesion molecule-related/down-regulated by oncogenes |
1766 |
0.31 |
chr9_91360032_91360505 | 9.50 |
Zic4 |
zinc finger protein of the cerebellum 4 |
2145 |
0.17 |
chr8_96455054_96456367 | 9.40 |
Gm32122 |
predicted gene, 32122 |
51848 |
0.14 |
chrX_133682515_133683917 | 9.33 |
Pcdh19 |
protocadherin 19 |
1775 |
0.49 |
chr8_45508499_45509041 | 9.32 |
Sorbs2 |
sorbin and SH3 domain containing 2 |
852 |
0.61 |
chr4_54950838_54951442 | 9.30 |
Zfp462 |
zinc finger protein 462 |
3164 |
0.35 |
chr11_36676450_36677161 | 9.26 |
Tenm2 |
teneurin transmembrane protein 2 |
940 |
0.7 |
chr10_29143400_29144848 | 9.23 |
Soga3 |
SOGA family member 3 |
65 |
0.5 |
chr1_14307063_14308005 | 9.02 |
Eya1 |
EYA transcriptional coactivator and phosphatase 1 |
2302 |
0.39 |
chr1_42259362_42260538 | 9.01 |
Gm28175 |
predicted gene 28175 |
1905 |
0.34 |
chr1_77505286_77506951 | 8.89 |
Epha4 |
Eph receptor A4 |
8961 |
0.18 |
chrX_61116034_61117613 | 8.87 |
Cdr1os |
cerebellar degeneration related antigen 1, opposite strand |
425 |
0.47 |
chr1_66386919_66387899 | 8.84 |
Map2 |
microtubule-associated protein 2 |
398 |
0.87 |
chr15_92598307_92599654 | 8.74 |
Pdzrn4 |
PDZ domain containing RING finger 4 |
1854 |
0.49 |
chr3_154816919_154817899 | 8.70 |
Gm18589 |
predicted gene, 18589 |
22198 |
0.2 |
chr18_23036665_23037864 | 8.69 |
Nol4 |
nucleolar protein 4 |
1392 |
0.59 |
chr8_12398370_12398923 | 8.43 |
Gm25239 |
predicted gene, 25239 |
2243 |
0.21 |
chr3_86545154_86545526 | 8.42 |
Lrba |
LPS-responsive beige-like anchor |
1415 |
0.43 |
chr13_28881136_28881895 | 8.41 |
2610307P16Rik |
RIKEN cDNA 2610307P16 gene |
1941 |
0.32 |
chr4_6986587_6987701 | 8.31 |
Tox |
thymocyte selection-associated high mobility group box |
3339 |
0.35 |
chr11_34315414_34316667 | 8.26 |
Insyn2b |
inhibitory synaptic factor family member 2B |
1218 |
0.45 |
chr1_14303973_14305599 | 8.22 |
Eya1 |
EYA transcriptional coactivator and phosphatase 1 |
158 |
0.97 |
chr10_92555787_92556921 | 8.20 |
Gm4800 |
predicted gene 4800 |
12684 |
0.16 |
chr4_48586297_48586448 | 8.18 |
Tmeff1 |
transmembrane protein with EGF-like and two follistatin-like domains 1 |
821 |
0.65 |
chr17_17402413_17403374 | 8.09 |
Lix1 |
limb and CNS expressed 1 |
221 |
0.91 |
chr17_11664263_11665109 | 7.87 |
Gm10513 |
predicted gene 10513 |
67659 |
0.13 |
chr10_33623738_33624906 | 7.85 |
Gm15939 |
predicted gene 15939 |
76 |
0.56 |
chr1_14308374_14310407 | 7.83 |
Eya1 |
EYA transcriptional coactivator and phosphatase 1 |
446 |
0.88 |
chr7_91090740_91091963 | 7.82 |
Dlg2 |
discs large MAGUK scaffold protein 2 |
623 |
0.71 |
chr15_25415436_25415919 | 7.78 |
Gm48957 |
predicted gene, 48957 |
614 |
0.58 |
chr6_96113911_96115198 | 7.72 |
Tafa1 |
TAFA chemokine like family member 1 |
95 |
0.98 |
chr14_59626952_59628434 | 7.70 |
Shisa2 |
shisa family member 2 |
504 |
0.76 |
chr2_6881042_6881689 | 7.67 |
Gm13389 |
predicted gene 13389 |
2905 |
0.24 |
chr1_12692796_12693687 | 7.53 |
Sulf1 |
sulfatase 1 |
709 |
0.67 |
chr16_43504464_43505047 | 7.51 |
Zbtb20 |
zinc finger and BTB domain containing 20 |
1058 |
0.61 |
chr13_83715222_83716973 | 7.48 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
5284 |
0.15 |
chr12_91683421_91686419 | 7.29 |
Gm16876 |
predicted gene, 16876 |
255 |
0.86 |
chr7_79501250_79502506 | 7.28 |
Mir9-3hg |
Mir9-3 host gene |
1757 |
0.18 |
chr7_62420525_62420893 | 7.27 |
Mkrn3 |
makorin, ring finger protein, 3 |
570 |
0.69 |
chr18_79106634_79106785 | 7.27 |
Setbp1 |
SET binding protein 1 |
2682 |
0.4 |
chr18_80984086_80984990 | 7.25 |
Sall3 |
spalt like transcription factor 3 |
1998 |
0.23 |
chr16_77236514_77236677 | 7.22 |
Mir99ahg |
Mir99a and Mirlet7c-1 host gene (non-protein coding) |
276 |
0.93 |
chr16_63863108_63864179 | 7.19 |
Epha3 |
Eph receptor A3 |
230 |
0.96 |
chr1_81077232_81078427 | 7.14 |
Nyap2 |
neuronal tyrosine-phophorylated phosphoinositide 3-kinase adaptor 2 |
246 |
0.96 |
chr3_68572046_68573169 | 7.12 |
Schip1 |
schwannomin interacting protein 1 |
362 |
0.89 |
chr5_135725023_135726457 | 7.08 |
Por |
P450 (cytochrome) oxidoreductase |
12 |
0.96 |
chr10_116096404_116096629 | 7.05 |
Taf7l2 |
Taf7l2 |
17076 |
0.23 |
chr18_75698090_75698241 | 7.01 |
Ctif |
CBP80/20-dependent translation initiation factor |
611 |
0.8 |
chr1_168426195_168428871 | 6.95 |
Pbx1 |
pre B cell leukemia homeobox 1 |
3971 |
0.3 |
chr16_16558986_16560577 | 6.95 |
Fgd4 |
FYVE, RhoGEF and PH domain containing 4 |
209 |
0.94 |
chr7_137318563_137320070 | 6.94 |
Ebf3 |
early B cell factor 3 |
4871 |
0.21 |
chr13_99443316_99444666 | 6.94 |
Map1b |
microtubule-associated protein 1B |
47 |
0.98 |
chr2_105675959_105678109 | 6.94 |
Pax6 |
paired box 6 |
905 |
0.54 |
chrX_166346941_166347276 | 6.85 |
Gpm6b |
glycoprotein m6b |
2266 |
0.36 |
chr9_74977325_74977617 | 6.79 |
Fam214a |
family with sequence similarity 214, member A |
1360 |
0.45 |
chr18_57468245_57468987 | 6.74 |
Ctxn3 |
cortexin 3 |
94 |
0.97 |
chr1_78193153_78194695 | 6.74 |
Pax3 |
paired box 3 |
2914 |
0.3 |
chr3_34653590_34654523 | 6.69 |
Sox2ot |
SOX2 overlapping transcript (non-protein coding) |
1980 |
0.2 |
chr8_22012864_22013642 | 6.67 |
Ccdc70 |
coiled-coil domain containing 70 |
42657 |
0.08 |
chr11_112197604_112198387 | 6.61 |
Gm11680 |
predicted gene 11680 |
90557 |
0.1 |
chr13_83735228_83735549 | 6.56 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
2822 |
0.16 |
chr12_65428156_65429051 | 6.53 |
Gm26015 |
predicted gene, 26015 |
22633 |
0.22 |
chr7_137311015_137311991 | 6.50 |
Ebf3 |
early B cell factor 3 |
2413 |
0.29 |
chr18_81509510_81510030 | 6.46 |
Gm50412 |
predicted gene, 50412 |
29413 |
0.19 |
chr11_94045498_94046076 | 6.44 |
Spag9 |
sperm associated antigen 9 |
1422 |
0.4 |
chr8_108716860_108718878 | 6.41 |
Zfhx3 |
zinc finger homeobox 3 |
3225 |
0.3 |
chr4_143298537_143299593 | 6.38 |
Pdpn |
podoplanin |
398 |
0.83 |
chr1_42703141_42704653 | 6.36 |
Pantr2 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 2 |
4155 |
0.16 |
chr8_49462071_49462635 | 6.31 |
4930555F03Rik |
RIKEN cDNA 4930555F03 gene |
970 |
0.52 |
chr12_46816152_46816702 | 6.28 |
Nova1 |
NOVA alternative splicing regulator 1 |
533 |
0.8 |
chrX_23283125_23283785 | 6.25 |
Klhl13 |
kelch-like 13 |
1374 |
0.57 |
chrX_69363262_69363944 | 6.23 |
Gm14705 |
predicted gene 14705 |
2334 |
0.33 |
chr9_52148115_52149635 | 6.22 |
Zc3h12c |
zinc finger CCCH type containing 12C |
19236 |
0.18 |
chr9_61376232_61377980 | 6.19 |
Tle3 |
transducin-like enhancer of split 3 |
1577 |
0.38 |
chr9_41587250_41587725 | 6.19 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
282 |
0.84 |
chr17_66869630_66870110 | 6.17 |
Gm49940 |
predicted gene, 49940 |
7630 |
0.18 |
chr13_34125172_34126139 | 6.16 |
Tubb2b |
tubulin, beta 2B class IIB |
4699 |
0.12 |
chr8_93812106_93812875 | 6.15 |
Gnao1 |
guanine nucleotide binding protein, alpha O |
1177 |
0.35 |
chr13_78196283_78196791 | 6.14 |
Nr2f1 |
nuclear receptor subfamily 2, group F, member 1 |
164 |
0.91 |
chr6_15188050_15189424 | 6.12 |
Foxp2 |
forkhead box P2 |
3174 |
0.4 |
chr4_110285249_110285423 | 6.10 |
Elavl4 |
ELAV like RNA binding protein 4 |
1280 |
0.61 |
chr18_72349127_72350542 | 6.09 |
Dcc |
deleted in colorectal carcinoma |
1183 |
0.64 |
chr11_94044930_94045437 | 6.08 |
Spag9 |
sperm associated antigen 9 |
818 |
0.6 |
chr14_76420544_76421824 | 6.07 |
Tsc22d1 |
TSC22 domain family, member 1 |
2356 |
0.39 |
chr6_55678280_55679200 | 6.07 |
Neurod6 |
neurogenic differentiation 6 |
2523 |
0.32 |
chr13_8202516_8203999 | 6.04 |
Adarb2 |
adenosine deaminase, RNA-specific, B2 |
335 |
0.87 |
chr3_34638141_34639272 | 6.04 |
Sox2ot |
SOX2 overlapping transcript (non-protein coding) |
202 |
0.53 |
chr4_33926104_33927188 | 6.02 |
Cnr1 |
cannabinoid receptor 1 (brain) |
444 |
0.88 |
chr9_41582824_41584205 | 6.01 |
Mir125b-1 |
microRNA 125b-1 |
1588 |
0.2 |
chr8_34325722_34326983 | 6.00 |
Gm4889 |
predicted gene 4889 |
1558 |
0.28 |
chr8_14382368_14383445 | 6.00 |
Dlgap2 |
DLG associated protein 2 |
910 |
0.66 |
chr5_115437597_115438427 | 5.93 |
4930430O22Rik |
RIKEN cDNA 4930430O22 gene |
1368 |
0.21 |
chr3_134330789_134331989 | 5.92 |
Gm43558 |
predicted gene 43558 |
25903 |
0.15 |
chr4_35844509_35845617 | 5.89 |
Lingo2 |
leucine rich repeat and Ig domain containing 2 |
141 |
0.98 |
chr13_52976109_52977372 | 5.89 |
Nfil3 |
nuclear factor, interleukin 3, regulated |
4333 |
0.2 |
chr9_69592532_69592902 | 5.89 |
Gm47203 |
predicted gene, 47203 |
7037 |
0.25 |
chr8_8657897_8658105 | 5.84 |
Efnb2 |
ephrin B2 |
3238 |
0.12 |
chr13_78189592_78191761 | 5.80 |
Nr2f1 |
nuclear receptor subfamily 2, group F, member 1 |
233 |
0.9 |
chr3_34646184_34646968 | 5.79 |
Gm42692 |
predicted gene 42692 |
3312 |
0.14 |
chr5_116895246_116895637 | 5.79 |
Gm43122 |
predicted gene 43122 |
64887 |
0.1 |
chr6_7554855_7556232 | 5.78 |
Tac1 |
tachykinin 1 |
447 |
0.85 |
chr15_98983254_98984205 | 5.78 |
4930578M01Rik |
RIKEN cDNA 4930578M01 gene |
102 |
0.93 |
chr6_85265029_85265433 | 5.77 |
Sfxn5 |
sideroflexin 5 |
298 |
0.89 |
chr18_69350551_69351104 | 5.76 |
Tcf4 |
transcription factor 4 |
1883 |
0.45 |
chr9_41584760_41585051 | 5.76 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
2864 |
0.14 |
chr14_28164563_28165084 | 5.76 |
Erc2 |
ELKS/RAB6-interacting/CAST family member 2 |
118395 |
0.06 |
chr1_109984209_109985108 | 5.75 |
Cdh7 |
cadherin 7, type 2 |
921 |
0.74 |
chr10_90577565_90578158 | 5.72 |
Anks1b |
ankyrin repeat and sterile alpha motif domain containing 1B |
869 |
0.72 |
chr11_118907285_118907593 | 5.71 |
Rbfox3 |
RNA binding protein, fox-1 homolog (C. elegans) 3 |
566 |
0.76 |
chr4_24429141_24429555 | 5.69 |
Gm27243 |
predicted gene 27243 |
1542 |
0.44 |
chr6_8955848_8957226 | 5.69 |
Nxph1 |
neurexophilin 1 |
6861 |
0.32 |
chr19_59462586_59463447 | 5.59 |
Emx2 |
empty spiracles homeobox 2 |
214 |
0.92 |
chr13_15550210_15550596 | 5.58 |
Gli3 |
GLI-Kruppel family member GLI3 |
86423 |
0.07 |
chr8_45507516_45508498 | 5.57 |
Sorbs2 |
sorbin and SH3 domain containing 2 |
89 |
0.97 |
chr5_131615202_131615755 | 5.56 |
2810432F15Rik |
RIKEN cDNA 2810432F15 gene |
40 |
0.94 |
chr8_8658122_8658842 | 5.55 |
Efnb2 |
ephrin B2 |
2757 |
0.13 |
chr8_110266991_110267758 | 5.55 |
Gm26832 |
predicted gene, 26832 |
88 |
0.83 |
chr12_47164059_47165060 | 5.54 |
Gm36971 |
predicted gene, 36971 |
483 |
0.87 |
chr3_144197270_144197856 | 5.51 |
Gm43445 |
predicted gene 43445 |
1699 |
0.34 |
chr2_73275777_73276681 | 5.49 |
Sp9 |
trans-acting transcription factor 9 |
4263 |
0.18 |
chr17_51760240_51761547 | 5.47 |
C230085N15Rik |
RIKEN cDNA C230085N15 gene |
728 |
0.54 |
chrX_58034447_58034953 | 5.45 |
Zic3 |
zinc finger protein of the cerebellum 3 |
3690 |
0.31 |
chr18_14502717_14503687 | 5.45 |
Gm50098 |
predicted gene, 50098 |
11197 |
0.23 |
chr10_73821409_73822534 | 5.41 |
Pcdh15 |
protocadherin 15 |
28 |
0.99 |
chr12_36315313_36316308 | 5.40 |
Sostdc1 |
sclerostin domain containing 1 |
1671 |
0.31 |
chr1_72577294_72577941 | 5.40 |
Smarcal1 |
SWI/SNF related matrix associated, actin dependent regulator of chromatin, subfamily a-like 1 |
5634 |
0.22 |
chr9_42573346_42573839 | 5.39 |
Tbcel |
tubulin folding cofactor E-like |
65783 |
0.11 |
chr13_48264468_48265300 | 5.38 |
A330033J07Rik |
RIKEN cDNA A330033J07 gene |
2261 |
0.19 |
chr10_109832096_109833441 | 5.38 |
Nav3 |
neuron navigator 3 |
453 |
0.9 |
chr7_137312340_137312685 | 5.34 |
Ebf3 |
early B cell factor 3 |
1404 |
0.43 |
chr13_44842150_44842855 | 5.33 |
Jarid2 |
jumonji, AT rich interactive domain 2 |
1719 |
0.39 |
chr2_181766837_181767244 | 5.33 |
Myt1 |
myelin transcription factor 1 |
2 |
0.97 |
chr13_119753686_119754726 | 5.32 |
Nim1k |
NIM1 serine/threonine protein kinase |
1676 |
0.22 |
chr11_44785075_44785303 | 5.32 |
Gm12158 |
predicted gene 12158 |
122513 |
0.05 |
chr5_48598987_48600332 | 5.30 |
Kcnip4 |
Kv channel interacting protein 4 |
23 |
0.97 |
chr3_66222231_66222730 | 5.26 |
Ptx3 |
pentraxin related gene |
2235 |
0.31 |
chr5_132509386_132509839 | 5.26 |
Gm43188 |
predicted gene 43188 |
9775 |
0.13 |
chr14_118362932_118364036 | 5.26 |
Gm26791 |
predicted gene, 26791 |
248 |
0.89 |
chr19_14777221_14777986 | 5.25 |
Gm26026 |
predicted gene, 26026 |
59123 |
0.15 |
chr8_89035789_89036490 | 5.22 |
Sall1 |
spalt like transcription factor 1 |
8023 |
0.23 |
chr2_32428080_32429746 | 5.22 |
Slc25a25 |
solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 25 |
1839 |
0.19 |
chr6_15196934_15197697 | 5.22 |
Foxp2 |
forkhead box P2 |
351 |
0.94 |
chr8_41054476_41055299 | 5.21 |
Mtus1 |
mitochondrial tumor suppressor 1 |
93 |
0.95 |
chr1_172056022_172057415 | 5.20 |
Nhlh1 |
nescient helix loop helix 1 |
855 |
0.45 |
chr13_83732205_83734272 | 5.20 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
672 |
0.58 |
chr7_49661650_49663134 | 5.20 |
Dbx1 |
developing brain homeobox 1 |
25543 |
0.21 |
chr5_107497766_107498034 | 5.19 |
Btbd8 |
BTB (POZ) domain containing 8 |
121 |
0.94 |
chr10_92404661_92405130 | 5.16 |
4930401A07Rik |
RIKEN cDNA 4930401A07 gene |
3881 |
0.24 |
chr13_99444676_99445299 | 5.13 |
Map1b |
microtubule-associated protein 1B |
520 |
0.79 |
chr17_90088736_90088977 | 5.13 |
Nrxn1 |
neurexin I |
456 |
0.9 |
chrX_105390628_105392456 | 5.12 |
5330434G04Rik |
RIKEN cDNA 5330434G04 gene |
212 |
0.93 |
chr7_79512487_79513145 | 5.11 |
2900037B21Rik |
RIKEN cDNA 2900037B21 gene |
108 |
0.91 |
chr14_98164357_98165375 | 5.10 |
Dach1 |
dachshund family transcription factor 1 |
4677 |
0.28 |
chr5_128482670_128483744 | 5.09 |
Gm42500 |
predicted gene 42500 |
34303 |
0.11 |
chr3_67892003_67892637 | 5.08 |
Iqschfp |
Iqcj and Schip1 fusion protein |
88 |
0.51 |
chr19_55749292_55750940 | 5.07 |
Tcf7l2 |
transcription factor 7 like 2, T cell specific, HMG box |
7271 |
0.3 |
chr6_23243939_23244913 | 5.07 |
Fezf1 |
Fez family zinc finger 1 |
3936 |
0.21 |
chr18_22345719_22346098 | 5.05 |
Asxl3 |
additional sex combs like 3, transcriptional regulator |
819 |
0.78 |
chr6_16727216_16727889 | 5.05 |
Gm36669 |
predicted gene, 36669 |
49972 |
0.17 |
chr7_36679043_36680470 | 5.03 |
Gm38285 |
predicted gene, 38285 |
15682 |
0.14 |
chr11_69834618_69835201 | 5.02 |
Nlgn2 |
neuroligin 2 |
60 |
0.9 |
chr14_31933288_31934260 | 5.02 |
D830044D21Rik |
RIKEN cDNA D830044D21 gene |
27246 |
0.16 |
chr18_80982763_80983698 | 5.02 |
Sall3 |
spalt like transcription factor 3 |
3306 |
0.17 |
chr15_30458403_30458947 | 5.02 |
Ctnnd2 |
catenin (cadherin associated protein), delta 2 |
887 |
0.67 |
chr8_47284401_47285223 | 5.02 |
Stox2 |
storkhead box 2 |
4550 |
0.27 |
chr1_42686011_42687379 | 5.02 |
Pantr1 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 1 |
6398 |
0.14 |
chr6_77242646_77243402 | 5.01 |
Lrrtm1 |
leucine rich repeat transmembrane neuronal 1 |
102 |
0.98 |
chr12_98577628_98578516 | 5.01 |
Kcnk10 |
potassium channel, subfamily K, member 10 |
238 |
0.9 |
chr2_92188323_92189316 | 5.00 |
Phf21a |
PHD finger protein 21A |
2354 |
0.24 |
chr18_69349288_69349439 | 4.99 |
Tcf4 |
transcription factor 4 |
419 |
0.89 |
chr3_144223529_144223825 | 4.99 |
Lmo4 |
LIM domain only 4 |
18457 |
0.18 |
chr14_100374663_100375528 | 4.99 |
Gm26367 |
predicted gene, 26367 |
43388 |
0.15 |
chr8_23669376_23670424 | 4.98 |
Zmat4 |
zinc finger, matrin type 4 |
226 |
0.95 |
chr6_103809934_103810942 | 4.95 |
Gm25656 |
predicted gene, 25656 |
22140 |
0.25 |
chr10_21882056_21883261 | 4.95 |
Sgk1 |
serum/glucocorticoid regulated kinase 1 |
289 |
0.9 |
chr1_111862798_111863699 | 4.93 |
Dsel |
dermatan sulfate epimerase-like |
1520 |
0.41 |
chr13_55962186_55963636 | 4.90 |
Gm47071 |
predicted gene, 47071 |
39354 |
0.14 |
chr10_90830503_90831025 | 4.90 |
Anks1b |
ankyrin repeat and sterile alpha motif domain containing 1B |
921 |
0.56 |
chr10_111247804_111248910 | 4.89 |
Osbpl8 |
oxysterol binding protein-like 8 |
289 |
0.91 |
chr7_109174148_109175577 | 4.89 |
Lmo1 |
LIM domain only 1 |
345 |
0.88 |
chr8_54723932_54725109 | 4.89 |
Wdr17 |
WD repeat domain 17 |
16 |
0.98 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.8 | 19.3 | GO:0060594 | mammary gland specification(GO:0060594) |
4.8 | 14.3 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
4.7 | 42.7 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
4.5 | 22.6 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
4.4 | 13.1 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
3.8 | 26.9 | GO:0042118 | endothelial cell activation(GO:0042118) |
3.7 | 11.1 | GO:0046552 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
3.5 | 24.7 | GO:0016198 | axon choice point recognition(GO:0016198) |
2.9 | 11.7 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
2.9 | 14.6 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
2.9 | 11.5 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
2.9 | 2.9 | GO:0072309 | mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis(GO:0072309) |
2.8 | 8.4 | GO:1903375 | cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) facioacoustic ganglion development(GO:1903375) |
2.8 | 8.3 | GO:0032474 | otolith morphogenesis(GO:0032474) |
2.6 | 10.5 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
2.6 | 7.7 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
2.3 | 11.6 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
2.3 | 6.9 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
2.3 | 6.9 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
2.3 | 6.8 | GO:0042126 | nitrate metabolic process(GO:0042126) |
2.1 | 8.6 | GO:0090427 | activation of meiosis(GO:0090427) |
2.1 | 8.6 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
2.1 | 4.2 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
2.0 | 22.5 | GO:0097120 | receptor localization to synapse(GO:0097120) |
2.0 | 8.1 | GO:0032512 | regulation of protein phosphatase type 2B activity(GO:0032512) |
2.0 | 8.0 | GO:0021978 | telencephalon regionalization(GO:0021978) |
2.0 | 4.0 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) |
2.0 | 4.0 | GO:0021825 | substrate-dependent cerebral cortex tangential migration(GO:0021825) |
2.0 | 15.7 | GO:2000794 | regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000794) |
2.0 | 3.9 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
2.0 | 13.7 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
1.9 | 13.5 | GO:0097264 | self proteolysis(GO:0097264) |
1.9 | 7.7 | GO:2000852 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
1.9 | 9.5 | GO:0072017 | distal tubule development(GO:0072017) |
1.9 | 7.5 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
1.8 | 9.2 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
1.8 | 5.5 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
1.8 | 1.8 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
1.8 | 5.3 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
1.7 | 1.7 | GO:0097475 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
1.7 | 5.2 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
1.7 | 3.4 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
1.7 | 18.5 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
1.7 | 5.0 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
1.6 | 6.6 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
1.6 | 6.6 | GO:0030035 | microspike assembly(GO:0030035) |
1.6 | 3.2 | GO:0021557 | oculomotor nerve development(GO:0021557) |
1.6 | 12.6 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
1.5 | 12.1 | GO:0071625 | vocalization behavior(GO:0071625) |
1.5 | 3.0 | GO:1904339 | negative regulation of dopaminergic neuron differentiation(GO:1904339) |
1.5 | 4.5 | GO:0071492 | cellular response to UV-A(GO:0071492) |
1.5 | 22.1 | GO:0008038 | neuron recognition(GO:0008038) |
1.5 | 5.9 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
1.5 | 4.4 | GO:0046684 | response to pyrethroid(GO:0046684) |
1.5 | 4.4 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
1.4 | 7.0 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
1.4 | 4.2 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
1.4 | 4.1 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
1.3 | 4.0 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
1.3 | 3.9 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
1.3 | 1.3 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
1.3 | 5.2 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
1.3 | 3.8 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
1.3 | 1.3 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
1.3 | 3.8 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
1.3 | 3.8 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
1.3 | 1.3 | GO:0072191 | ureter smooth muscle development(GO:0072191) ureter smooth muscle cell differentiation(GO:0072193) |
1.2 | 3.7 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) |
1.2 | 3.7 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
1.2 | 2.5 | GO:0072092 | ureteric bud invasion(GO:0072092) |
1.2 | 4.9 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
1.2 | 15.7 | GO:0021884 | forebrain neuron development(GO:0021884) |
1.2 | 6.0 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
1.2 | 2.4 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
1.2 | 4.7 | GO:0006551 | leucine metabolic process(GO:0006551) |
1.2 | 2.3 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
1.1 | 2.3 | GO:0035262 | gonad morphogenesis(GO:0035262) |
1.1 | 5.5 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
1.1 | 2.2 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
1.1 | 2.1 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
1.1 | 2.1 | GO:0060166 | olfactory pit development(GO:0060166) |
1.1 | 3.2 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
1.0 | 3.1 | GO:0002877 | regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) |
1.0 | 3.1 | GO:0060174 | limb bud formation(GO:0060174) |
1.0 | 1.0 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
1.0 | 13.2 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
1.0 | 2.0 | GO:0021553 | olfactory nerve development(GO:0021553) |
1.0 | 3.0 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
1.0 | 4.0 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
1.0 | 5.9 | GO:0015884 | folic acid transport(GO:0015884) |
1.0 | 1.0 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
1.0 | 1.0 | GO:0033504 | floor plate development(GO:0033504) |
1.0 | 3.8 | GO:0001927 | exocyst assembly(GO:0001927) |
1.0 | 5.7 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.9 | 4.7 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.9 | 3.7 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.9 | 3.5 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.9 | 2.6 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.9 | 7.9 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.9 | 1.8 | GO:0021877 | forebrain neuron fate commitment(GO:0021877) |
0.9 | 3.5 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.9 | 2.6 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.9 | 0.9 | GO:0014029 | neural crest formation(GO:0014029) |
0.9 | 6.0 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.8 | 2.5 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.8 | 0.8 | GO:0061743 | motor learning(GO:0061743) |
0.8 | 3.3 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.8 | 1.7 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.8 | 1.7 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
0.8 | 0.8 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
0.8 | 1.7 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.8 | 12.4 | GO:0060074 | synapse maturation(GO:0060074) |
0.8 | 4.1 | GO:0061309 | cardiac neural crest cell development involved in outflow tract morphogenesis(GO:0061309) |
0.8 | 8.2 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.8 | 17.9 | GO:0001964 | startle response(GO:0001964) |
0.8 | 2.4 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.8 | 2.4 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.8 | 4.8 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.8 | 6.4 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.8 | 3.2 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.8 | 1.6 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.8 | 13.3 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.8 | 2.3 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.8 | 1.6 | GO:0060513 | prostatic bud formation(GO:0060513) |
0.8 | 1.6 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.8 | 0.8 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
0.8 | 1.5 | GO:0060437 | lung growth(GO:0060437) |
0.8 | 1.5 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.7 | 3.7 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.7 | 0.7 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.7 | 10.2 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.7 | 0.7 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.7 | 0.7 | GO:0070384 | Harderian gland development(GO:0070384) |
0.7 | 7.2 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.7 | 0.7 | GO:1904861 | excitatory synapse assembly(GO:1904861) |
0.7 | 4.3 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.7 | 0.7 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.7 | 4.2 | GO:2000980 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.7 | 4.2 | GO:0060179 | male mating behavior(GO:0060179) |
0.7 | 1.4 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.7 | 1.4 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.7 | 1.4 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
0.7 | 6.8 | GO:0035640 | exploration behavior(GO:0035640) |
0.7 | 3.4 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
0.7 | 1.4 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.7 | 2.7 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.7 | 2.0 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.7 | 2.7 | GO:0021544 | subpallium development(GO:0021544) |
0.7 | 2.7 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.7 | 2.0 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
0.7 | 1.3 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.7 | 5.9 | GO:0072498 | embryonic skeletal joint development(GO:0072498) |
0.6 | 49.1 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.6 | 3.2 | GO:0035989 | tendon development(GO:0035989) |
0.6 | 1.9 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.6 | 2.5 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.6 | 3.1 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.6 | 2.4 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.6 | 17.1 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.6 | 1.8 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.6 | 0.6 | GO:0061642 | chemoattraction of axon(GO:0061642) |
0.6 | 1.8 | GO:0060023 | soft palate development(GO:0060023) |
0.6 | 5.4 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.6 | 5.4 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.6 | 1.8 | GO:0045112 | integrin biosynthetic process(GO:0045112) regulation of integrin biosynthetic process(GO:0045113) |
0.6 | 6.5 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
0.6 | 13.5 | GO:0021766 | hippocampus development(GO:0021766) |
0.6 | 0.6 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.6 | 0.6 | GO:0021855 | hypothalamus cell migration(GO:0021855) |
0.6 | 2.3 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.6 | 1.2 | GO:1901535 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
0.6 | 2.9 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.6 | 1.1 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
0.6 | 2.3 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.6 | 1.1 | GO:0060618 | nipple development(GO:0060618) |
0.6 | 0.6 | GO:1901166 | neural crest cell migration involved in autonomic nervous system development(GO:1901166) |
0.6 | 2.8 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.6 | 1.1 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.6 | 8.3 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.5 | 0.5 | GO:0072174 | metanephric tubule formation(GO:0072174) |
0.5 | 8.1 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.5 | 0.5 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
0.5 | 5.9 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.5 | 4.8 | GO:0021514 | ventral spinal cord interneuron differentiation(GO:0021514) |
0.5 | 5.8 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.5 | 22.6 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.5 | 1.6 | GO:0030432 | peristalsis(GO:0030432) |
0.5 | 1.6 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
0.5 | 1.6 | GO:0052203 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.5 | 1.5 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.5 | 3.6 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.5 | 0.5 | GO:0060872 | semicircular canal development(GO:0060872) |
0.5 | 1.0 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.5 | 2.0 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.5 | 3.9 | GO:0042428 | serotonin metabolic process(GO:0042428) |
0.5 | 0.5 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.5 | 1.5 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
0.5 | 2.4 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.5 | 1.5 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.5 | 1.0 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.5 | 15.5 | GO:0019228 | neuronal action potential(GO:0019228) |
0.5 | 2.9 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.5 | 1.0 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
0.5 | 1.0 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.5 | 1.0 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.5 | 1.4 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.5 | 3.8 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.5 | 1.9 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.5 | 1.4 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.5 | 0.9 | GO:1990123 | L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
0.5 | 1.8 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.5 | 0.5 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
0.5 | 0.5 | GO:0048880 | sensory system development(GO:0048880) |
0.4 | 0.9 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.4 | 0.4 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.4 | 0.4 | GO:2000729 | mesenchymal cell proliferation involved in ureter development(GO:0072198) regulation of mesenchymal cell proliferation involved in ureter development(GO:0072199) positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
0.4 | 0.4 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
0.4 | 1.3 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
0.4 | 1.7 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.4 | 0.9 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.4 | 0.4 | GO:0032100 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
0.4 | 1.7 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.4 | 2.1 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.4 | 0.8 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.4 | 2.5 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.4 | 1.2 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.4 | 1.2 | GO:0021914 | smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021910) negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.4 | 1.6 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.4 | 2.8 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.4 | 1.6 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.4 | 4.7 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.4 | 0.4 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.4 | 10.6 | GO:0001755 | neural crest cell migration(GO:0001755) |
0.4 | 4.3 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.4 | 3.1 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.4 | 1.5 | GO:0046909 | intermembrane transport(GO:0046909) |
0.4 | 1.5 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.4 | 4.9 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.4 | 0.4 | GO:0090494 | catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
0.4 | 1.1 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.4 | 0.8 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.4 | 1.1 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.4 | 7.9 | GO:0007416 | synapse assembly(GO:0007416) |
0.4 | 0.7 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.4 | 5.5 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.4 | 2.2 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.4 | 1.1 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.4 | 1.1 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.4 | 0.7 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.4 | 0.4 | GO:0052428 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.4 | 0.7 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
0.4 | 1.1 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
0.4 | 2.1 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.3 | 0.3 | GO:0060065 | uterus development(GO:0060065) |
0.3 | 0.7 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.3 | 0.3 | GO:2000822 | regulation of fear response(GO:1903365) positive regulation of fear response(GO:1903367) regulation of behavioral fear response(GO:2000822) positive regulation of behavioral fear response(GO:2000987) |
0.3 | 1.4 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.3 | 0.7 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.3 | 0.3 | GO:0033092 | positive regulation of immature T cell proliferation in thymus(GO:0033092) |
0.3 | 1.4 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.3 | 0.3 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.3 | 0.7 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.3 | 0.3 | GO:0061055 | myotome development(GO:0061055) |
0.3 | 23.2 | GO:0007411 | axon guidance(GO:0007411) |
0.3 | 0.3 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.3 | 2.0 | GO:0009068 | aspartate family amino acid catabolic process(GO:0009068) |
0.3 | 0.3 | GO:0015740 | C4-dicarboxylate transport(GO:0015740) |
0.3 | 1.3 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.3 | 0.7 | GO:0043309 | regulation of eosinophil degranulation(GO:0043309) |
0.3 | 2.0 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.3 | 0.3 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.3 | 1.3 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.3 | 1.9 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.3 | 0.6 | GO:0003383 | apical constriction(GO:0003383) |
0.3 | 0.6 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.3 | 3.5 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.3 | 1.0 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.3 | 1.0 | GO:0021854 | hypothalamus development(GO:0021854) |
0.3 | 2.2 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.3 | 0.9 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.3 | 2.8 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.3 | 4.6 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.3 | 0.6 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.3 | 0.9 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.3 | 1.2 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.3 | 0.3 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) |
0.3 | 0.9 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.3 | 1.5 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.3 | 0.9 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.3 | 0.3 | GO:0097485 | neuron projection guidance(GO:0097485) |
0.3 | 1.5 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.3 | 4.2 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
0.3 | 1.2 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.3 | 0.3 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.3 | 0.3 | GO:0060585 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.3 | 2.6 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.3 | 0.6 | GO:0003051 | angiotensin-mediated drinking behavior(GO:0003051) |
0.3 | 3.7 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.3 | 0.6 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.3 | 0.3 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
0.3 | 0.8 | GO:1990035 | calcium ion import into cell(GO:1990035) |
0.3 | 0.8 | GO:0097503 | sialylation(GO:0097503) |
0.3 | 2.0 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.3 | 2.2 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.3 | 0.3 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.3 | 0.8 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.3 | 0.5 | GO:0002666 | positive regulation of T cell tolerance induction(GO:0002666) |
0.3 | 1.1 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.3 | 1.3 | GO:0021936 | regulation of cerebellar granule cell precursor proliferation(GO:0021936) |
0.3 | 0.5 | GO:0032349 | positive regulation of aldosterone metabolic process(GO:0032346) positive regulation of aldosterone biosynthetic process(GO:0032349) |
0.3 | 0.8 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.3 | 0.3 | GO:0038091 | VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
0.3 | 1.1 | GO:2001182 | regulation of interleukin-12 secretion(GO:2001182) |
0.3 | 0.5 | GO:0090238 | positive regulation of arachidonic acid secretion(GO:0090238) |
0.3 | 1.3 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.3 | 0.5 | GO:0021794 | thalamus development(GO:0021794) |
0.3 | 0.3 | GO:0070350 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
0.3 | 0.5 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.3 | 0.8 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.3 | 0.8 | GO:0090179 | planar cell polarity pathway involved in neural tube closure(GO:0090179) |
0.3 | 1.0 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
0.2 | 0.2 | GO:0061038 | uterus morphogenesis(GO:0061038) |
0.2 | 1.0 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.2 | 1.0 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.2 | 0.5 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.2 | 1.5 | GO:0006477 | protein sulfation(GO:0006477) |
0.2 | 0.7 | GO:0050942 | positive regulation of developmental pigmentation(GO:0048087) positive regulation of pigment cell differentiation(GO:0050942) |
0.2 | 0.2 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.2 | 1.0 | GO:0042637 | catagen(GO:0042637) |
0.2 | 1.2 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.2 | 1.4 | GO:0048643 | positive regulation of skeletal muscle tissue development(GO:0048643) |
0.2 | 0.2 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.2 | 0.5 | GO:0015817 | histidine transport(GO:0015817) |
0.2 | 1.2 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.2 | 4.7 | GO:1904888 | cranial skeletal system development(GO:1904888) |
0.2 | 0.9 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.2 | 1.6 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.2 | 1.4 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.2 | 0.5 | GO:0070948 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.2 | 1.1 | GO:0000012 | single strand break repair(GO:0000012) |
0.2 | 0.9 | GO:0016115 | terpenoid catabolic process(GO:0016115) |
0.2 | 0.5 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.2 | 2.0 | GO:0019430 | removal of superoxide radicals(GO:0019430) |
0.2 | 0.7 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.2 | 0.7 | GO:1902896 | terminal web assembly(GO:1902896) |
0.2 | 0.4 | GO:0021904 | dorsal/ventral neural tube patterning(GO:0021904) |
0.2 | 0.2 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.2 | 0.7 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.2 | 1.3 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.2 | 3.9 | GO:0047496 | vesicle transport along microtubule(GO:0047496) |
0.2 | 0.9 | GO:0014028 | notochord formation(GO:0014028) |
0.2 | 2.8 | GO:0031111 | negative regulation of microtubule polymerization or depolymerization(GO:0031111) |
0.2 | 0.9 | GO:0030091 | protein repair(GO:0030091) |
0.2 | 0.6 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.2 | 1.7 | GO:0006183 | GTP biosynthetic process(GO:0006183) |
0.2 | 0.4 | GO:0007442 | hindgut morphogenesis(GO:0007442) |
0.2 | 0.6 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.2 | 0.2 | GO:0035984 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.2 | 0.4 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.2 | 2.5 | GO:0006743 | ubiquinone metabolic process(GO:0006743) |
0.2 | 0.4 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.2 | 0.4 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.2 | 0.8 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.2 | 6.7 | GO:0050808 | synapse organization(GO:0050808) |
0.2 | 0.6 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.2 | 0.8 | GO:0033136 | serine phosphorylation of STAT3 protein(GO:0033136) |
0.2 | 0.4 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.2 | 0.8 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.2 | 1.0 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.2 | 0.4 | GO:0071899 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
0.2 | 1.6 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.2 | 0.6 | GO:0010255 | carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
0.2 | 0.4 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.2 | 0.8 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.2 | 0.4 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.2 | 1.0 | GO:0034651 | cortisol biosynthetic process(GO:0034651) |
0.2 | 3.7 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.2 | 0.4 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.2 | 0.6 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.2 | 1.4 | GO:0030825 | positive regulation of cGMP metabolic process(GO:0030825) |
0.2 | 1.2 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.2 | 0.6 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.2 | 0.6 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.2 | 0.6 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
0.2 | 0.8 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.2 | 0.9 | GO:0002158 | osteoclast proliferation(GO:0002158) |
0.2 | 0.2 | GO:0072553 | terminal button organization(GO:0072553) |
0.2 | 0.6 | GO:0021930 | cell proliferation in external granule layer(GO:0021924) cerebellar granule cell precursor proliferation(GO:0021930) |
0.2 | 0.6 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.2 | 3.7 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.2 | 4.0 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.2 | 0.2 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) |
0.2 | 3.1 | GO:0032350 | regulation of hormone metabolic process(GO:0032350) |
0.2 | 0.4 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.2 | 0.4 | GO:0072307 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
0.2 | 1.6 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.2 | 0.4 | GO:0022038 | corpus callosum development(GO:0022038) |
0.2 | 1.1 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.2 | 1.8 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.2 | 0.5 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.2 | 0.5 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.2 | 0.7 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.2 | 0.5 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.2 | 0.7 | GO:1990403 | embryonic brain development(GO:1990403) |
0.2 | 0.7 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.2 | 0.5 | GO:0015755 | fructose transport(GO:0015755) |
0.2 | 1.0 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.2 | 0.5 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.2 | 0.7 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.2 | 0.2 | GO:0003347 | epicardial cell to mesenchymal cell transition(GO:0003347) |
0.2 | 0.7 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.2 | 0.2 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.2 | 0.5 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.2 | 0.3 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.2 | 1.4 | GO:0042772 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) DNA damage response, signal transduction resulting in transcription(GO:0042772) |
0.2 | 0.5 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.2 | 5.3 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.2 | 0.3 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.2 | 0.8 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
0.2 | 0.2 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.2 | 0.5 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.2 | 0.3 | GO:2000598 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.2 | 1.5 | GO:0032401 | establishment of melanosome localization(GO:0032401) |
0.2 | 1.1 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.2 | 0.5 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.2 | 1.4 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.2 | 0.2 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.2 | 0.6 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.2 | 4.5 | GO:1900006 | positive regulation of dendrite development(GO:1900006) |
0.2 | 0.6 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.2 | 0.8 | GO:0043970 | histone H3-K9 acetylation(GO:0043970) |
0.2 | 0.9 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
0.2 | 0.5 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.2 | 0.5 | GO:0015747 | urate transport(GO:0015747) |
0.2 | 0.2 | GO:1902805 | positive regulation of synaptic vesicle transport(GO:1902805) |
0.2 | 0.5 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.2 | 2.2 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
0.2 | 1.2 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.2 | 0.5 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.2 | 2.6 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.2 | 0.3 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.2 | 0.5 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.2 | 0.5 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.2 | 0.3 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.2 | 0.3 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.2 | 0.3 | GO:0014819 | regulation of skeletal muscle contraction(GO:0014819) |
0.1 | 0.1 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.1 | 0.6 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.1 | 0.3 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.1 | 0.1 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
0.1 | 0.1 | GO:0034241 | positive regulation of macrophage fusion(GO:0034241) |
0.1 | 1.7 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.1 | 0.3 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.1 | 1.2 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.1 | 0.9 | GO:0015846 | polyamine transport(GO:0015846) |
0.1 | 0.6 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.1 | 1.8 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.1 | 0.1 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.1 | 0.1 | GO:1903748 | negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
0.1 | 2.7 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.1 | 0.3 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.1 | 1.4 | GO:0002176 | male germ cell proliferation(GO:0002176) |
0.1 | 0.6 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.1 | 0.1 | GO:1904995 | negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.1 | 0.5 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.1 | 0.3 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.1 | 0.7 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.1 | 0.5 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.1 | 1.9 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.1 | 1.5 | GO:0036065 | fucosylation(GO:0036065) |
0.1 | 1.3 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.1 | 0.4 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.1 | 0.1 | GO:0071451 | cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) |
0.1 | 0.4 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.1 | 0.7 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.1 | 0.4 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.1 | 0.4 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.1 | 0.3 | GO:0034650 | cortisol metabolic process(GO:0034650) |
0.1 | 0.4 | GO:0032439 | endosome localization(GO:0032439) |
0.1 | 0.9 | GO:0098762 | meiotic prophase I(GO:0007128) prophase(GO:0051324) meiotic cell cycle phase(GO:0098762) meiosis I cell cycle phase(GO:0098764) |
0.1 | 0.3 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.1 | 0.4 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
0.1 | 4.9 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.1 | 0.8 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.1 | 0.1 | GO:0036118 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.1 | 6.6 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.1 | 0.3 | GO:1903659 | regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
0.1 | 1.8 | GO:0035329 | hippo signaling(GO:0035329) |
0.1 | 0.1 | GO:0030826 | regulation of cGMP biosynthetic process(GO:0030826) regulation of guanylate cyclase activity(GO:0031282) |
0.1 | 0.1 | GO:0071504 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
0.1 | 1.0 | GO:0010842 | retina layer formation(GO:0010842) |
0.1 | 2.9 | GO:0030514 | negative regulation of BMP signaling pathway(GO:0030514) |
0.1 | 0.1 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.1 | 0.2 | GO:0060751 | branch elongation involved in mammary gland duct branching(GO:0060751) |
0.1 | 0.2 | GO:0009629 | response to gravity(GO:0009629) |
0.1 | 0.1 | GO:0042661 | regulation of mesodermal cell fate specification(GO:0042661) |
0.1 | 0.4 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
0.1 | 0.1 | GO:0060157 | urinary bladder development(GO:0060157) |
0.1 | 0.8 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.1 | 1.4 | GO:0044550 | secondary metabolite biosynthetic process(GO:0044550) |
0.1 | 0.2 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.1 | 1.2 | GO:0003334 | keratinocyte development(GO:0003334) |
0.1 | 0.5 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.1 | 0.2 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.1 | 0.9 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.1 | 0.3 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.1 | 0.1 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.1 | 0.1 | GO:0061110 | dense core granule biogenesis(GO:0061110) |
0.1 | 0.6 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.1 | 0.8 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.1 | 1.3 | GO:0007616 | long-term memory(GO:0007616) |
0.1 | 0.7 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.1 | 0.1 | GO:0035283 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.1 | 0.2 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
0.1 | 0.2 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.1 | 0.2 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.1 | 1.7 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.1 | 1.4 | GO:0042491 | auditory receptor cell differentiation(GO:0042491) |
0.1 | 0.1 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.1 | 0.3 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.1 | 0.2 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.1 | 0.1 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.1 | 0.1 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
0.1 | 0.1 | GO:1904238 | mesangial cell differentiation(GO:0072007) glomerular mesangial cell differentiation(GO:0072008) kidney interstitial fibroblast differentiation(GO:0072071) renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) glomerular mesangial cell development(GO:0072144) pericyte cell differentiation(GO:1904238) |
0.1 | 1.1 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
0.1 | 0.8 | GO:0010388 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
0.1 | 0.2 | GO:0001807 | regulation of type IV hypersensitivity(GO:0001807) |
0.1 | 0.2 | GO:0033122 | negative regulation of purine nucleotide catabolic process(GO:0033122) |
0.1 | 0.1 | GO:0002447 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
0.1 | 0.6 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.1 | 0.1 | GO:0010909 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.1 | 0.1 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.1 | 0.3 | GO:0002215 | defense response to nematode(GO:0002215) |
0.1 | 0.3 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.1 | 0.2 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.1 | 0.1 | GO:2000553 | positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
0.1 | 0.3 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.1 | 0.1 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.1 | 1.0 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.1 | 0.7 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.1 | 0.7 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) |
0.1 | 0.3 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.1 | 0.5 | GO:0070977 | bone maturation(GO:0070977) |
0.1 | 7.8 | GO:0050953 | sensory perception of light stimulus(GO:0050953) |
0.1 | 0.2 | GO:0001555 | oocyte growth(GO:0001555) |
0.1 | 0.1 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.1 | 0.3 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.1 | 0.5 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.1 | 0.3 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.1 | 0.1 | GO:0010841 | positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) |
0.1 | 0.1 | GO:0014901 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
0.1 | 0.5 | GO:0023019 | signal transduction involved in regulation of gene expression(GO:0023019) |
0.1 | 0.3 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.1 | 0.2 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.1 | 0.3 | GO:0016322 | neuron remodeling(GO:0016322) |
0.1 | 0.6 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.1 | 0.3 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.1 | 0.8 | GO:0032094 | response to food(GO:0032094) |
0.1 | 0.7 | GO:0043486 | histone exchange(GO:0043486) |
0.1 | 0.2 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.1 | 0.6 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.1 | 0.3 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.1 | 0.6 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.1 | 0.5 | GO:0071569 | protein ufmylation(GO:0071569) |
0.1 | 0.2 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.1 | 0.4 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.1 | 0.2 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
0.1 | 0.2 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.1 | 0.2 | GO:0090383 | phagosome acidification(GO:0090383) |
0.1 | 0.2 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.1 | 0.2 | GO:0001546 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
0.1 | 0.2 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.1 | 0.3 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.1 | 0.2 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.1 | 0.1 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.1 | 0.2 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.1 | 0.4 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.1 | 0.4 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.1 | 0.3 | GO:0033762 | response to glucagon(GO:0033762) |
0.1 | 0.1 | GO:0072366 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
0.1 | 0.3 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
0.1 | 0.3 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.1 | 0.1 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.1 | 0.1 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.1 | 0.1 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.1 | 0.3 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.1 | 0.1 | GO:0021511 | spinal cord patterning(GO:0021511) |
0.1 | 0.2 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.1 | 0.3 | GO:2000288 | positive regulation of myoblast proliferation(GO:2000288) |
0.1 | 0.3 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.1 | 0.1 | GO:0033227 | dsRNA transport(GO:0033227) |
0.1 | 0.1 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.1 | 0.1 | GO:0051182 | coenzyme transport(GO:0051182) |
0.1 | 0.5 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.1 | 0.1 | GO:0045415 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
0.1 | 0.1 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.1 | 0.1 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.1 | 3.7 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.1 | 0.1 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.1 | 0.1 | GO:0009732 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.1 | 0.1 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.1 | 0.1 | GO:0008355 | olfactory learning(GO:0008355) |
0.1 | 0.3 | GO:0035090 | maintenance of apical/basal cell polarity(GO:0035090) |
0.1 | 0.1 | GO:0021534 | cell proliferation in hindbrain(GO:0021534) |
0.1 | 1.1 | GO:0008589 | regulation of smoothened signaling pathway(GO:0008589) |
0.1 | 0.1 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
0.1 | 0.7 | GO:0043949 | regulation of cAMP-mediated signaling(GO:0043949) |
0.1 | 0.3 | GO:0046836 | glycolipid transport(GO:0046836) |
0.1 | 0.2 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.1 | 0.2 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.1 | 0.1 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
0.1 | 0.4 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.1 | 0.1 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.1 | 0.2 | GO:0015819 | lysine transport(GO:0015819) |
0.1 | 0.4 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.1 | 0.2 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.1 | 0.3 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.1 | 0.2 | GO:0010288 | response to lead ion(GO:0010288) |
0.1 | 0.2 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.1 | 0.1 | GO:0061047 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.1 | 0.1 | GO:0042505 | tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
0.1 | 0.2 | GO:0042891 | antibiotic transport(GO:0042891) |
0.1 | 0.1 | GO:0030576 | Cajal body organization(GO:0030576) |
0.1 | 0.1 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.1 | 0.1 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.1 | 0.2 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.1 | 0.3 | GO:0043649 | dicarboxylic acid catabolic process(GO:0043649) |
0.1 | 0.4 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.1 | 0.5 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.1 | 0.2 | GO:1900363 | regulation of mRNA polyadenylation(GO:1900363) |
0.1 | 0.1 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
0.1 | 0.1 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.1 | 0.2 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.1 | 0.1 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.1 | 0.1 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.1 | 0.1 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.1 | 0.4 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 0.2 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.1 | 0.1 | GO:1901663 | quinone biosynthetic process(GO:1901663) |
0.1 | 1.3 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 0.1 | GO:0045343 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
0.1 | 0.1 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.1 | 0.2 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.0 | 0.1 | GO:2000109 | macrophage apoptotic process(GO:0071888) regulation of macrophage apoptotic process(GO:2000109) |
0.0 | 0.8 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.0 | 0.1 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.0 | 0.0 | GO:0010935 | regulation of macrophage cytokine production(GO:0010935) |
0.0 | 0.1 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.0 | 0.1 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
0.0 | 0.1 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.0 | 0.1 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.0 | 0.3 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.0 | 0.1 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.0 | 0.0 | GO:0072610 | interleukin-12 secretion(GO:0072610) |
0.0 | 0.1 | GO:1904970 | brush border assembly(GO:1904970) |
0.0 | 0.1 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.0 | 0.2 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.0 | 0.1 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.0 | 0.1 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.0 | 0.0 | GO:0072718 | response to cisplatin(GO:0072718) |
0.0 | 0.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.1 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.0 | 0.1 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.0 | 0.3 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.0 | 0.2 | GO:0044597 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.0 | 0.0 | GO:0060242 | contact inhibition(GO:0060242) |
0.0 | 0.1 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.0 | 0.2 | GO:0035878 | nail development(GO:0035878) |
0.0 | 0.0 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.0 | 0.1 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.0 | 0.4 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.0 | 0.1 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.0 | 0.3 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.0 | 0.1 | GO:0048262 | determination of dorsal/ventral asymmetry(GO:0048262) determination of dorsal identity(GO:0048263) |
0.0 | 0.0 | GO:0032415 | regulation of sodium:proton antiporter activity(GO:0032415) |
0.0 | 0.1 | GO:0006216 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.0 | 0.1 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.0 | 0.1 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
0.0 | 0.1 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
0.0 | 0.1 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.0 | 0.2 | GO:0030540 | female genitalia development(GO:0030540) |
0.0 | 0.6 | GO:0061387 | regulation of extent of cell growth(GO:0061387) |
0.0 | 0.0 | GO:0051709 | regulation of killing of cells of other organism(GO:0051709) |
0.0 | 0.3 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.0 | 0.2 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.0 | 0.0 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.0 | 0.0 | GO:0070141 | response to UV-A(GO:0070141) |
0.0 | 0.3 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.0 | 0.1 | GO:0051466 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.0 | 0.1 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
0.0 | 0.1 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.0 | 0.1 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.0 | 0.0 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.0 | 0.0 | GO:0007501 | mesodermal cell fate specification(GO:0007501) |
0.0 | 0.1 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.0 | 0.0 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.0 | 0.2 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.0 | 0.2 | GO:2000318 | positive regulation of T-helper 17 type immune response(GO:2000318) |
0.0 | 0.0 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.0 | 0.1 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.0 | 0.1 | GO:0035357 | peroxisome proliferator activated receptor signaling pathway(GO:0035357) |
0.0 | 0.0 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
0.0 | 0.1 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
0.0 | 0.0 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.0 | 0.1 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.0 | 0.0 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.0 | 0.0 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.0 | 0.1 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.0 | 0.1 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.0 | 0.1 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
0.0 | 0.1 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.0 | 0.2 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.0 | 0.1 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.0 | 0.1 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.0 | 1.1 | GO:0007566 | embryo implantation(GO:0007566) |
0.0 | 0.0 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
0.0 | 0.0 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
0.0 | 0.0 | GO:0031052 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.0 | 0.1 | GO:1902219 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.0 | 0.1 | GO:0036257 | multivesicular body organization(GO:0036257) |
0.0 | 0.1 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.0 | 0.1 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.0 | 0.1 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.0 | 0.1 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.0 | 0.1 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.0 | 0.0 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.0 | 0.0 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.0 | 0.2 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.0 | 0.1 | GO:0019287 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.0 | 0.1 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
0.0 | 0.3 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.0 | 0.0 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
0.0 | 0.1 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.0 | 0.9 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
0.0 | 0.1 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.0 | 0.0 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.0 | 0.1 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.0 | 0.7 | GO:0007224 | smoothened signaling pathway(GO:0007224) |
0.0 | 0.1 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
0.0 | 0.0 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.0 | 0.0 | GO:0036315 | cellular response to sterol(GO:0036315) |
0.0 | 0.0 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.0 | 0.0 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.0 | 0.0 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
0.0 | 0.5 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.0 | 0.0 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.0 | 0.0 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.0 | 0.0 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
0.0 | 0.1 | GO:0097421 | liver regeneration(GO:0097421) |
0.0 | 0.4 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.0 | 0.0 | GO:0002432 | granuloma formation(GO:0002432) |
0.0 | 0.1 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.0 | 0.0 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.0 | 0.6 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.0 | 0.1 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
0.0 | 0.0 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.0 | 0.1 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.0 | 0.0 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.0 | 0.0 | GO:0070640 | vitamin D3 metabolic process(GO:0070640) |
0.0 | 0.0 | GO:0060459 | left lung development(GO:0060459) left lung morphogenesis(GO:0060460) |
0.0 | 0.0 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.0 | 0.1 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.0 | 0.1 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.0 | 0.1 | GO:0030007 | cellular potassium ion homeostasis(GO:0030007) |
0.0 | 0.1 | GO:0045686 | negative regulation of glial cell differentiation(GO:0045686) |
0.0 | 0.0 | GO:0002339 | B cell selection(GO:0002339) |
0.0 | 0.0 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.0 | 0.1 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.0 | 0.0 | GO:0006531 | aspartate metabolic process(GO:0006531) |
0.0 | 0.1 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.0 | 0.0 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.0 | 0.0 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.0 | 0.0 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
0.0 | 0.1 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.0 | 0.0 | GO:0035947 | regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter(GO:0035947) |
0.0 | 0.0 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.0 | 0.0 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
0.0 | 0.0 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
0.0 | 0.0 | GO:0030823 | regulation of cGMP metabolic process(GO:0030823) |
0.0 | 0.0 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.0 | 0.0 | GO:0021983 | pituitary gland development(GO:0021983) |
0.0 | 0.0 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.0 | 0.0 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.0 | 0.0 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
0.0 | 0.0 | GO:1901160 | primary amino compound metabolic process(GO:1901160) |
0.0 | 0.2 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.0 | 0.1 | GO:0045687 | positive regulation of glial cell differentiation(GO:0045687) |
0.0 | 0.0 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.0 | 0.0 | GO:0044154 | histone H3-K14 acetylation(GO:0044154) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.1 | 2.1 | GO:0044294 | dendritic growth cone(GO:0044294) |
1.9 | 5.7 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
1.5 | 14.5 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
1.4 | 38.8 | GO:0044295 | axonal growth cone(GO:0044295) |
1.3 | 8.0 | GO:0032584 | growth cone membrane(GO:0032584) |
1.3 | 6.5 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
1.2 | 18.0 | GO:0043196 | varicosity(GO:0043196) |
1.1 | 9.2 | GO:0042788 | polysomal ribosome(GO:0042788) |
1.1 | 5.6 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
1.1 | 3.4 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
1.1 | 4.4 | GO:1990696 | USH2 complex(GO:1990696) |
1.0 | 14.4 | GO:0031527 | filopodium membrane(GO:0031527) |
0.9 | 8.9 | GO:0030673 | axolemma(GO:0030673) |
0.9 | 2.7 | GO:0072534 | perineuronal net(GO:0072534) |
0.9 | 9.5 | GO:0097449 | astrocyte projection(GO:0097449) |
0.8 | 38.9 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.7 | 0.7 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.7 | 2.1 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.7 | 7.5 | GO:0043194 | axon initial segment(GO:0043194) |
0.7 | 4.1 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.7 | 4.7 | GO:0043083 | synaptic cleft(GO:0043083) |
0.7 | 2.0 | GO:0033010 | paranodal junction(GO:0033010) |
0.7 | 2.0 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.6 | 5.0 | GO:0097470 | ribbon synapse(GO:0097470) |
0.6 | 1.8 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.6 | 7.9 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.6 | 2.4 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.6 | 1.7 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.6 | 5.1 | GO:0005883 | neurofilament(GO:0005883) |
0.6 | 6.1 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.5 | 2.2 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.5 | 2.0 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.5 | 12.5 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.5 | 13.9 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.5 | 2.9 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.5 | 1.4 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.4 | 4.5 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.4 | 5.8 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.4 | 5.3 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.4 | 42.5 | GO:0030426 | growth cone(GO:0030426) |
0.4 | 3.0 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.4 | 3.0 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.4 | 1.2 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.4 | 3.7 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.4 | 0.8 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.4 | 1.6 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.4 | 0.4 | GO:0035838 | growing cell tip(GO:0035838) |
0.4 | 4.7 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.4 | 35.3 | GO:0043204 | perikaryon(GO:0043204) |
0.4 | 20.1 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.4 | 1.8 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.3 | 5.9 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.3 | 0.7 | GO:0097441 | basilar dendrite(GO:0097441) |
0.3 | 1.0 | GO:0097427 | microtubule bundle(GO:0097427) |
0.3 | 44.6 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.3 | 1.4 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.3 | 2.0 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.3 | 3.5 | GO:0031045 | dense core granule(GO:0031045) |
0.3 | 1.6 | GO:0097433 | dense body(GO:0097433) |
0.3 | 2.2 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.3 | 2.5 | GO:0097440 | apical dendrite(GO:0097440) |
0.3 | 0.3 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.3 | 3.3 | GO:0035102 | PRC1 complex(GO:0035102) |
0.3 | 2.4 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.3 | 0.6 | GO:0071439 | clathrin complex(GO:0071439) |
0.3 | 3.4 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.3 | 5.3 | GO:0005922 | connexon complex(GO:0005922) |
0.3 | 1.0 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.3 | 0.5 | GO:0000322 | storage vacuole(GO:0000322) |
0.2 | 0.7 | GO:1990357 | terminal web(GO:1990357) |
0.2 | 1.0 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.2 | 0.5 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.2 | 0.5 | GO:0030286 | dynein complex(GO:0030286) |
0.2 | 1.1 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.2 | 0.7 | GO:0061574 | ASAP complex(GO:0061574) |
0.2 | 0.7 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.2 | 0.6 | GO:0016342 | catenin complex(GO:0016342) |
0.2 | 3.2 | GO:0090568 | nuclear transcriptional repressor complex(GO:0090568) |
0.2 | 0.8 | GO:0043203 | axon hillock(GO:0043203) |
0.2 | 0.2 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.2 | 6.7 | GO:0030175 | filopodium(GO:0030175) |
0.2 | 0.6 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.2 | 0.8 | GO:0071953 | elastic fiber(GO:0071953) |
0.2 | 6.3 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.2 | 3.1 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.2 | 0.9 | GO:0071547 | piP-body(GO:0071547) |
0.2 | 0.6 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.2 | 62.1 | GO:0005667 | transcription factor complex(GO:0005667) |
0.2 | 1.6 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.2 | 3.9 | GO:0016235 | aggresome(GO:0016235) |
0.2 | 0.3 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.2 | 0.7 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.2 | 0.2 | GO:0044393 | microspike(GO:0044393) |
0.2 | 1.0 | GO:0016012 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.2 | 1.5 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.2 | 1.9 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.2 | 1.0 | GO:0044292 | dendrite terminus(GO:0044292) |
0.2 | 11.4 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.2 | 1.3 | GO:0097542 | ciliary tip(GO:0097542) |
0.2 | 0.6 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.1 | 0.7 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.1 | 1.3 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.1 | 0.4 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.1 | 3.2 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.1 | 0.6 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.1 | 1.1 | GO:0097546 | ciliary base(GO:0097546) |
0.1 | 0.5 | GO:0005955 | calcineurin complex(GO:0005955) |
0.1 | 0.4 | GO:1990393 | 3M complex(GO:1990393) |
0.1 | 2.6 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.1 | 0.2 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.1 | 0.6 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.1 | 0.7 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.1 | 1.0 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.1 | 14.2 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 1.2 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.1 | 0.9 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.1 | 4.5 | GO:0031012 | extracellular matrix(GO:0031012) |
0.1 | 3.3 | GO:0032421 | stereocilium bundle(GO:0032421) |
0.1 | 0.3 | GO:0036396 | MIS complex(GO:0036396) |
0.1 | 1.2 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 0.2 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.1 | 0.3 | GO:0000802 | transverse filament(GO:0000802) |
0.1 | 0.6 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.1 | 0.5 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 0.1 | GO:0044327 | dendritic spine head(GO:0044327) |
0.1 | 6.1 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.1 | 0.1 | GO:0098984 | neuron to neuron synapse(GO:0098984) |
0.1 | 0.1 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.1 | 0.3 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.1 | 0.2 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.1 | 0.7 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.1 | 0.5 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.1 | 0.5 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 0.4 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.1 | 0.3 | GO:0070545 | PeBoW complex(GO:0070545) |
0.1 | 0.9 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.4 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.3 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.1 | 0.2 | GO:0042827 | platelet dense granule(GO:0042827) |
0.1 | 0.1 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.1 | 0.3 | GO:0000812 | Swr1 complex(GO:0000812) |
0.1 | 0.2 | GO:1990423 | RZZ complex(GO:1990423) |
0.1 | 0.2 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 1.0 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 0.1 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.1 | 2.3 | GO:0045095 | keratin filament(GO:0045095) |
0.1 | 16.6 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.1 | 0.4 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 0.7 | GO:0097060 | synaptic membrane(GO:0097060) |
0.1 | 0.4 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 0.2 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 0.1 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.1 | 0.8 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 0.2 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.1 | 0.7 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 0.4 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.0 | 0.1 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.0 | 0.1 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.0 | 10.1 | GO:0043025 | neuronal cell body(GO:0043025) |
0.0 | 0.4 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.0 | 0.1 | GO:0044194 | cytolytic granule(GO:0044194) |
0.0 | 0.1 | GO:0016589 | NURF complex(GO:0016589) |
0.0 | 0.1 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.0 | 1.5 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 0.1 | GO:0071797 | LUBAC complex(GO:0071797) |
0.0 | 0.2 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.0 | 0.2 | GO:0071546 | pi-body(GO:0071546) |
0.0 | 0.1 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.0 | 0.2 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.0 | 0.1 | GO:0005745 | m-AAA complex(GO:0005745) |
0.0 | 2.1 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.0 | 0.6 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 2.5 | GO:0031513 | nonmotile primary cilium(GO:0031513) |
0.0 | 0.2 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.0 | 0.2 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) |
0.0 | 1.3 | GO:0044297 | cell body(GO:0044297) |
0.0 | 0.4 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 0.1 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.0 | 0.1 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.0 | 0.8 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.0 | 0.1 | GO:0030427 | site of polarized growth(GO:0030427) |
0.0 | 0.1 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.0 | 0.1 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.0 | 0.1 | GO:0043293 | apoptosome(GO:0043293) |
0.0 | 0.1 | GO:0042825 | TAP complex(GO:0042825) |
0.0 | 0.1 | GO:0000938 | GARP complex(GO:0000938) |
0.0 | 0.0 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.0 | 0.1 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.0 | 0.1 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.0 | 0.0 | GO:0035363 | histone locus body(GO:0035363) |
0.0 | 0.0 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
10.0 | 30.1 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
5.5 | 27.4 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
3.7 | 14.6 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
3.1 | 27.6 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
3.0 | 9.1 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
2.8 | 19.9 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
2.6 | 7.7 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
2.2 | 6.5 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
2.1 | 6.3 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
1.9 | 13.0 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
1.9 | 3.7 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
1.8 | 9.2 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
1.7 | 5.1 | GO:0045503 | dynein light chain binding(GO:0045503) |
1.7 | 10.0 | GO:0004385 | guanylate kinase activity(GO:0004385) |
1.7 | 5.0 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
1.6 | 3.2 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
1.5 | 4.6 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
1.5 | 6.2 | GO:0005042 | netrin receptor activity(GO:0005042) |
1.5 | 10.6 | GO:0003680 | AT DNA binding(GO:0003680) |
1.5 | 6.0 | GO:0034056 | estrogen response element binding(GO:0034056) |
1.4 | 7.0 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
1.3 | 2.6 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
1.3 | 7.7 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
1.2 | 6.2 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
1.2 | 11.1 | GO:0038191 | neuropilin binding(GO:0038191) |
1.2 | 2.4 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
1.2 | 11.9 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
1.1 | 3.4 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
1.1 | 4.5 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
1.1 | 3.2 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
1.0 | 7.1 | GO:0043495 | protein anchor(GO:0043495) |
1.0 | 3.0 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
1.0 | 5.9 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.9 | 11.4 | GO:0015172 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
0.9 | 15.8 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.9 | 5.5 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.9 | 1.7 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.9 | 5.1 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
0.8 | 2.5 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.8 | 2.4 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.8 | 1.6 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
0.8 | 2.4 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.8 | 3.2 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.8 | 19.2 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.8 | 3.8 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.8 | 16.0 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.7 | 2.2 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.7 | 2.2 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.7 | 2.9 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.7 | 3.6 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.7 | 2.9 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.7 | 7.1 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.7 | 2.1 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.7 | 4.9 | GO:0036122 | BMP binding(GO:0036122) |
0.7 | 2.0 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.7 | 0.7 | GO:0051378 | serotonin binding(GO:0051378) |
0.7 | 2.0 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.7 | 8.5 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.6 | 5.8 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.6 | 3.7 | GO:0046790 | virion binding(GO:0046790) |
0.6 | 4.9 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.6 | 2.4 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.6 | 1.8 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.6 | 17.6 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.6 | 11.1 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.5 | 2.7 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.5 | 2.7 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.5 | 7.1 | GO:0035198 | miRNA binding(GO:0035198) |
0.5 | 8.1 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.5 | 2.1 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.5 | 2.6 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.5 | 4.6 | GO:0039706 | co-receptor binding(GO:0039706) |
0.5 | 9.6 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.5 | 3.5 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.5 | 4.9 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.5 | 1.0 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.5 | 1.9 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.5 | 3.3 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.5 | 0.9 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.5 | 1.4 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.5 | 2.3 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.4 | 0.4 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.4 | 15.7 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.4 | 3.0 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.4 | 12.8 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.4 | 10.9 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.4 | 1.2 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.4 | 1.2 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.4 | 1.9 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.4 | 1.1 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.4 | 7.5 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.4 | 1.9 | GO:0048495 | Roundabout binding(GO:0048495) |
0.4 | 1.1 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.4 | 5.5 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.4 | 5.1 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.4 | 1.1 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
0.4 | 8.3 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.4 | 1.4 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.3 | 2.7 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.3 | 1.0 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.3 | 1.0 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.3 | 1.7 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.3 | 7.0 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.3 | 0.3 | GO:0015556 | C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
0.3 | 2.0 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.3 | 2.0 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.3 | 1.9 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.3 | 1.3 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.3 | 1.3 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.3 | 2.2 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.3 | 6.1 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.3 | 6.0 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.3 | 4.7 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.3 | 1.9 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.3 | 0.6 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.3 | 4.0 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.3 | 3.7 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.3 | 3.3 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.3 | 7.8 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.3 | 3.3 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.3 | 4.8 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.3 | 2.6 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.3 | 1.2 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.3 | 1.2 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.3 | 2.0 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.3 | 5.2 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.3 | 2.6 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.3 | 0.8 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.3 | 0.8 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.3 | 0.3 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.3 | 0.8 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.3 | 1.1 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.3 | 0.8 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
0.3 | 1.6 | GO:0030957 | Tat protein binding(GO:0030957) |
0.3 | 1.6 | GO:0004673 | protein histidine kinase activity(GO:0004673) phosphotransferase activity, nitrogenous group as acceptor(GO:0016775) |
0.3 | 1.0 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.3 | 0.3 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.3 | 1.3 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.3 | 1.3 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.3 | 1.3 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.2 | 3.0 | GO:0031005 | filamin binding(GO:0031005) |
0.2 | 1.0 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.2 | 1.0 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.2 | 0.5 | GO:1990188 | euchromatin binding(GO:1990188) |
0.2 | 2.4 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.2 | 2.1 | GO:0015026 | coreceptor activity(GO:0015026) |
0.2 | 0.7 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.2 | 19.7 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.2 | 2.4 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.2 | 0.4 | GO:0098811 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.2 | 0.7 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.2 | 4.1 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.2 | 2.0 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.2 | 0.6 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.2 | 0.6 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.2 | 1.9 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.2 | 0.8 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.2 | 1.6 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.2 | 0.6 | GO:0034046 | poly(G) binding(GO:0034046) |
0.2 | 7.7 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.2 | 2.8 | GO:0030275 | LRR domain binding(GO:0030275) |
0.2 | 0.6 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.2 | 1.0 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.2 | 0.6 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.2 | 1.2 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.2 | 0.8 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.2 | 0.8 | GO:0001191 | transcriptional repressor activity, RNA polymerase II transcription factor binding(GO:0001191) |
0.2 | 0.6 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.2 | 0.8 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.2 | 0.6 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.2 | 0.4 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.2 | 1.5 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.2 | 0.7 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.2 | 1.6 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.2 | 2.5 | GO:0030955 | potassium ion binding(GO:0030955) |
0.2 | 2.5 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.2 | 0.7 | GO:0034584 | piRNA binding(GO:0034584) |
0.2 | 0.5 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.2 | 0.5 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.2 | 0.3 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.2 | 0.9 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.2 | 0.8 | GO:1990254 | keratin filament binding(GO:1990254) |
0.2 | 0.5 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.2 | 2.0 | GO:0070402 | NADPH binding(GO:0070402) |
0.2 | 2.5 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.2 | 0.8 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.2 | 0.2 | GO:0043398 | HLH domain binding(GO:0043398) |
0.2 | 0.5 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.2 | 1.3 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.2 | 0.8 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.2 | 0.2 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.2 | 2.2 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.2 | 2.5 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.2 | 1.0 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.2 | 0.3 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.2 | 1.1 | GO:0070888 | E-box binding(GO:0070888) |
0.2 | 0.5 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.2 | 0.6 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.2 | 0.2 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.2 | 0.8 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.2 | 3.0 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.1 | 0.7 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.1 | 0.3 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.1 | 10.7 | GO:0005262 | calcium channel activity(GO:0005262) |
0.1 | 0.7 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.1 | 1.7 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.1 | 0.6 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.1 | 0.6 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.1 | 0.4 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.1 | 0.4 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.1 | 0.1 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.1 | 2.4 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 1.0 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.1 | 4.6 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.1 | 0.4 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.1 | 0.7 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 1.6 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.1 | 0.1 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.1 | 0.4 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.1 | 3.1 | GO:0008483 | transaminase activity(GO:0008483) |
0.1 | 5.0 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 40.1 | GO:0000987 | core promoter proximal region sequence-specific DNA binding(GO:0000987) |
0.1 | 1.5 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.1 | 0.8 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 0.4 | GO:0034813 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.1 | 0.3 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.1 | 0.1 | GO:0001135 | transcription factor activity, transcription factor recruiting(GO:0001134) transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.1 | 0.4 | GO:2001069 | glycogen binding(GO:2001069) |
0.1 | 1.6 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 1.5 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.4 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.1 | 2.1 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 0.1 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.1 | 0.6 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 0.2 | GO:0048030 | disaccharide binding(GO:0048030) |
0.1 | 0.5 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.1 | 0.4 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.1 | 0.6 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 2.0 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 2.1 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.1 | 0.3 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.1 | 0.7 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.1 | 0.7 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.1 | 1.9 | GO:0031489 | myosin V binding(GO:0031489) |
0.1 | 23.8 | GO:0000976 | transcription regulatory region sequence-specific DNA binding(GO:0000976) |
0.1 | 0.5 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.1 | 2.2 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 2.3 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 0.3 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.1 | 0.8 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.1 | 0.1 | GO:0034925 | mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
0.1 | 1.1 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 0.5 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.1 | 1.9 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 0.2 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.1 | 0.3 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.1 | 0.5 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.1 | 2.0 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 0.1 | GO:0051425 | PTB domain binding(GO:0051425) |
0.1 | 0.4 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.1 | 0.1 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.1 | 0.3 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.1 | 2.4 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.1 | 0.2 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.1 | 0.3 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.1 | 0.2 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.1 | 4.1 | GO:0019905 | syntaxin binding(GO:0019905) |
0.1 | 0.5 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 0.2 | GO:0097016 | L27 domain binding(GO:0097016) |
0.1 | 5.6 | GO:0000975 | regulatory region DNA binding(GO:0000975) |
0.1 | 0.8 | GO:0005272 | sodium channel activity(GO:0005272) |
0.1 | 0.3 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.1 | 0.9 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.1 | 5.3 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.1 | 2.2 | GO:0017022 | myosin binding(GO:0017022) |
0.1 | 0.6 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.1 | 21.3 | GO:0043565 | sequence-specific DNA binding(GO:0043565) |
0.1 | 0.5 | GO:0102337 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.1 | 0.1 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.1 | 0.4 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 0.4 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.1 | 0.2 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.1 | 0.9 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 0.1 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.1 | 0.1 | GO:0051373 | FATZ binding(GO:0051373) |
0.1 | 0.1 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.1 | 0.2 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.1 | 0.3 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.1 | 0.2 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.1 | 0.3 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.1 | 0.3 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
0.1 | 0.3 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.1 | 0.3 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.1 | 0.3 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 0.3 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.1 | 0.5 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.1 | 0.3 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.1 | 0.1 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.1 | 0.2 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 1.7 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.1 | 0.8 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 0.1 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.1 | 0.4 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.1 | 0.5 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.1 | 0.1 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.1 | 1.6 | GO:0008009 | chemokine activity(GO:0008009) |
0.1 | 0.3 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.1 | 0.1 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.1 | 0.1 | GO:0032190 | acrosin binding(GO:0032190) |
0.1 | 0.1 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.1 | 0.2 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.1 | 0.4 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.1 | 0.1 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.1 | 0.2 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.1 | 0.2 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.1 | 5.1 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.3 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.1 | 1.1 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 0.1 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.1 | 0.2 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.1 | 1.0 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.1 | 0.1 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.0 | 0.4 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.0 | 0.1 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.0 | 1.2 | GO:0052770 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.0 | 0.5 | GO:0005310 | dicarboxylic acid transmembrane transporter activity(GO:0005310) |
0.0 | 0.0 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.0 | 0.2 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.0 | 0.1 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.0 | 0.2 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.0 | 0.1 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.0 | 0.4 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
0.0 | 0.0 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.0 | 0.4 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.0 | 0.8 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.0 | 0.6 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.0 | 0.2 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.0 | 0.1 | GO:0002046 | opsin binding(GO:0002046) |
0.0 | 11.1 | GO:0003700 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.0 | 0.1 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.0 | 0.1 | GO:0005534 | galactose binding(GO:0005534) |
0.0 | 0.2 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.0 | 0.1 | GO:0089720 | caspase binding(GO:0089720) |
0.0 | 1.1 | GO:0005261 | cation channel activity(GO:0005261) |
0.0 | 0.0 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.0 | 1.0 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 0.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.1 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.0 | 0.0 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.0 | 0.1 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.0 | 0.0 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.0 | 0.2 | GO:0016936 | galactoside binding(GO:0016936) |
0.0 | 0.1 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.0 | 0.1 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.0 | 0.3 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.0 | 0.4 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.0 | 0.1 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.0 | 0.1 | GO:0070840 | dynein complex binding(GO:0070840) |
0.0 | 0.1 | GO:0008506 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.0 | 0.1 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.0 | 0.1 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.0 | 0.1 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.0 | 0.3 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.0 | 0.3 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.0 | 0.2 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.0 | 0.1 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.0 | 0.1 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.0 | 0.1 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.0 | 0.1 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.0 | 0.8 | GO:0016247 | channel regulator activity(GO:0016247) |
0.0 | 0.1 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.0 | 0.1 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.0 | 0.1 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.0 | 0.1 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.0 | 0.1 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.0 | 0.4 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.2 | GO:0015211 | purine nucleoside transmembrane transporter activity(GO:0015211) |
0.0 | 0.1 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.0 | 0.0 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.0 | 0.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.0 | 0.1 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.0 | 0.0 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.0 | 0.1 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.0 | 0.2 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.0 | 0.1 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.0 | 0.1 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.0 | 0.1 | GO:0046979 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.0 | 0.2 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.0 | 0.0 | GO:0038100 | nodal binding(GO:0038100) |
0.0 | 0.1 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.0 | 0.2 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.0 | 0.1 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.0 | 0.1 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.0 | 0.1 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.0 | 0.1 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.0 | 0.1 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.0 | 0.0 | GO:0050051 | leukotriene-B4 20-monooxygenase activity(GO:0050051) |
0.0 | 0.1 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.0 | 0.0 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.0 | 0.1 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.0 | 0.0 | GO:0046428 | 4-hydroxybenzoate octaprenyltransferase activity(GO:0008412) protoheme IX farnesyltransferase activity(GO:0008495) (S)-2,3-di-O-geranylgeranylglyceryl phosphate synthase activity(GO:0043888) cadaverine aminopropyltransferase activity(GO:0043918) agmatine aminopropyltransferase activity(GO:0043919) 1,4-dihydroxy-2-naphthoate octaprenyltransferase activity(GO:0046428) trans-pentaprenyltranstransferase activity(GO:0048045) ATP dimethylallyltransferase activity(GO:0052622) ADP dimethylallyltransferase activity(GO:0052623) |
0.0 | 0.1 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.0 | 0.1 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.0 | 0.0 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.0 | 0.0 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.0 | 0.0 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.0 | 0.2 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.0 | 0.1 | GO:0031386 | protein tag(GO:0031386) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 14.7 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.8 | 22.8 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.7 | 52.8 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.7 | 4.1 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.6 | 18.9 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.6 | 16.1 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.6 | 12.5 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.5 | 14.0 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.5 | 7.1 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.5 | 5.9 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.5 | 11.9 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.4 | 5.8 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.3 | 2.1 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.3 | 3.8 | PID ALK2 PATHWAY | ALK2 signaling events |
0.3 | 9.5 | PID LKB1 PATHWAY | LKB1 signaling events |
0.3 | 4.6 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.3 | 3.5 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.2 | 0.9 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.2 | 2.6 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.2 | 2.1 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.2 | 3.2 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.2 | 2.9 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.2 | 5.8 | PID FGF PATHWAY | FGF signaling pathway |
0.2 | 2.8 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.2 | 0.8 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.1 | 0.1 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.1 | 1.9 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 0.6 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.1 | 1.5 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 0.3 | PID IFNG PATHWAY | IFN-gamma pathway |
0.1 | 5.3 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 0.4 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.1 | 5.0 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 0.1 | PID REELIN PATHWAY | Reelin signaling pathway |
0.1 | 1.7 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.1 | 0.3 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.1 | 1.3 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 3.0 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 0.9 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 2.8 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 0.2 | PID IGF1 PATHWAY | IGF1 pathway |
0.1 | 0.7 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 0.7 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 0.4 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 2.3 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 1.4 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 0.9 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 0.3 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 2.5 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 1.4 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.1 | 0.1 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 1.5 | PID CDC42 PATHWAY | CDC42 signaling events |
0.1 | 6.8 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 2.0 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 10.1 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.3 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 0.2 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 0.2 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 1.3 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.0 | 0.0 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.0 | 0.0 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.0 | 0.3 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 0.2 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 0.0 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 0.1 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 0.1 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 0.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.0 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 0.0 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 0.1 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.0 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.9 | 1.9 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
1.6 | 41.0 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
1.4 | 24.7 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
1.3 | 10.6 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
1.2 | 16.9 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.9 | 12.3 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.8 | 8.3 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.7 | 11.0 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.6 | 6.6 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.6 | 8.7 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.5 | 16.4 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.5 | 10.6 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.5 | 1.4 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.4 | 4.9 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.4 | 1.7 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.4 | 6.6 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.4 | 1.6 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.4 | 7.8 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.4 | 4.2 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.4 | 4.0 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.3 | 1.0 | REACTOME ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING | Genes involved in Activation of Kainate Receptors upon glutamate binding |
0.3 | 0.7 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.3 | 3.2 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.3 | 0.3 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
0.3 | 9.5 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.3 | 3.8 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.3 | 6.5 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.3 | 11.3 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.3 | 0.3 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.3 | 7.0 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.3 | 13.2 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.3 | 18.1 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.3 | 2.5 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.3 | 5.1 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.3 | 4.4 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.2 | 2.9 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.2 | 7.9 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.2 | 0.4 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.2 | 8.9 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.2 | 0.4 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.2 | 3.4 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.2 | 2.4 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.2 | 0.3 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.2 | 2.9 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.2 | 1.3 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.2 | 0.2 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.2 | 1.4 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 0.6 | REACTOME SIGNALING BY FGFR | Genes involved in Signaling by FGFR |
0.1 | 1.5 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.1 | 2.3 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 5.3 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 1.0 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 2.8 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 0.1 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.1 | 3.8 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.1 | 0.5 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.1 | 3.7 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
0.1 | 0.5 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.1 | 1.9 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 1.4 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.1 | 0.5 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.1 | 1.2 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.1 | 0.2 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.1 | 0.3 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
0.1 | 1.8 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.1 | 0.1 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.1 | 0.3 | REACTOME NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Neurotransmitter Release Cycle |
0.1 | 1.6 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.1 | 0.2 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.1 | 0.8 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.1 | 0.6 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.1 | 4.6 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.1 | 0.1 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.1 | 0.2 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.1 | 1.1 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.1 | 0.8 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.1 | 1.4 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.1 | 1.3 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 10.6 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 0.8 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.1 | 0.1 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.1 | 0.1 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.1 | 1.0 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 0.6 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 0.4 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.1 | 0.6 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.1 | 0.7 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 0.9 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 0.2 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.0 | 0.7 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 0.0 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.0 | 0.0 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.0 | 0.1 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.0 | 0.3 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.0 | 0.0 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.0 | 0.3 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.3 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.0 | 0.4 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.0 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.0 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.0 | 0.0 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.0 | 0.1 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.0 | 0.3 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |